Photo taken from Drew Moghanaki/X
Sep 17, 2023, 18:35
Drew Moghanaki: Here is a trio of ongoing adjuvant studies for patients with stage IA NSCLC.
Drew Moghanaki, at , shared on Twitter:
“Here is a trio of ongoing adjuvant studies for patients with stage IA NSCLC. If either is positive, patients with stage IA may soon have to choose between Surgery+Observe and SBRT+ICI.”
Source: Drew Moghanaki/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 15:20
Nov 19, 2024, 15:17
Nov 19, 2024, 15:14
Nov 19, 2024, 15:12
Nov 19, 2024, 14:54
Nov 19, 2024, 14:42
Nov 19, 2024, 14:20